During the past decade, Klinika Chorób Wewnetrznych i Alergologii MSW conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinika Chorób Wewnetrznych i Alergologii MSW" are "Asthma" (3 trials). Many other conditions were trialed in "Klinika Chorób Wewnetrznych i Alergologii MSW" in a lesser frequency.

Most popular intervention types in "Klinika Chorób Wewnetrznych i Alergologii MSW" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (3 trials), "Placebo" (3 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinika Chorób Wewnetrznych i Alergologii MSW" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Klinika Chorób Wewnetrznych i Alergologii MSW". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinika Chorób Wewnetrznych i Alergologii MSW, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinika Chorób Wewnetrznych i Alergologii MSW, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".